Announcement & Circular > Article details
Voluntary Announcement Approval Obtained for Initiating Clinical Trial for the Innovative ADC Candidate BA1301 for Injection in China
2023.01.09 | Boan Biotech,Shandong Boan Biotech, Boan Innovative Antibodies,Boan Biosimilar